Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) is a heterogeneous and aggressive type of T-cell lymphoma. Here, the authors perform single-cell analyses of human and murine PTCL ...

This is compared to 83% ... Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma June 19, 2024 — Researchers have developed a non ...

In a recent study published in Nature Cancer, researchers explore treatment resistance and relapse in T-cell acute ...

Mixed cellularity Hodgkin lymphoma is a type of Hodgkin disease, a cancer of lymph cells. It is the second most common type of classical Hodgkin disease. About 15% to 30% of all individuals with ...

Pulmonary lymphoma is a rare cancer in which lymphoma cells affect your lungs. It can start inside the lungs (primary) or elsewhere in the body and spread to the lungs (secondary). Lymphoma occurs ...

Lineage Cell Therapeutics (AMEX:LCTX) is gearing up to announce its quarterly earnings on Thursday, 2024-11-14. Here's a quick overview of what investors should know before the release.

“(My doctors) said, ‘Hey, we wish we had better news, but you have non-Hodgkin lymphoma, B-cell lymphoma,’” Coulier recalls. “It was a shock.” Despite his cancer diagnosis, Coulier is ...

Seven patients with heavily pretreated large B-cell lymphoma (LBCL) that a CD19 CAR-T therapy had not halted had received the asset in question, dubbed NKX019. Of these individuals, five achieved ...

“Three days later, my doctors called me back and they said, ‘We wish we had better news for you, but you have non-Hodgkin's lymphoma and it's called B cell and it's very aggressive,’” he ...